The Venture Codex Logo

The Venture Codex

Overview

Developing selective PI3K inhibitors for cancer and inflammatory diseases.

Total Raised

$12 M

Rounds

2

Links

Verticals

Biotechnology
Medical Device
Therapeutics

Investment History

  1. Equity

    May 2011

    $8M

  2. Series A

    Aug 2010

    $5M

Team